Login / Signup

Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.

Kazuyoshi KakehiYoshitaka IwanagaHeitaro WatanabeTakashi SonobeTsuyoshi AkiyamaShuji ShimizuHiromi YamamotoShunichi Miyazaki
Published in: Journal of cardiovascular pharmacology and therapeutics (2019)
IVA therapy improved the survival of hypertensive animals with HF. Furthermore, it was associated with the amelioration of systemic sympathetic activation and cardiac sympathetic and parasympathetic nerve innervations. Chronic β-blocker therapy with negative inotropic effects had beneficial effects only on cardiac innervations.
Keyphrases
  • heart failure
  • left ventricular
  • blood pressure
  • acute heart failure
  • atrial fibrillation
  • mesenchymal stem cells
  • cardiac resynchronization therapy